Potkul, R. K., Unger, J. M., Livingston, R. B., Crew, K. D., Wilczynski, S. P., Salomon, C. G., . . . Albain, K. S. (2016). Randomized trial of medroxyprogesterone acetate for the prevention of endometrial pathology from adjuvant tamoxifen for breast cancer: SWOG S9630. NPJ Breast Cancer.
استشهاد بنمط شيكاغوPotkul, Ronald K., et al. "Randomized Trial of Medroxyprogesterone Acetate for the Prevention of Endometrial Pathology From Adjuvant Tamoxifen for Breast Cancer: SWOG S9630." NPJ Breast Cancer 2016.
MLA استشهادPotkul, Ronald K., et al. "Randomized Trial of Medroxyprogesterone Acetate for the Prevention of Endometrial Pathology From Adjuvant Tamoxifen for Breast Cancer: SWOG S9630." NPJ Breast Cancer 2016.
تحذير: قد لا تكون هذه الاستشهادات دائما دقيقة بنسبة 100%.